基于 HIF1A/EZH2/ANTXR2 通路探讨罗氏内异方治疗子宫内膜 异位症大鼠的作用机制.Published in:Traditional Chinese Drug Research & Clinical Pharmacology, 2024, v. 35, n. 7, p. 993, doi. 10.19378/j.issn.1003-9783.2024.07.007By:裴芳利;贾金金;陈晓鑫;林树红;林增娴;吴李征;曾诚Publication type:Article
罗氏内异方调控缺氧干预子宫内膜异位症 SF-1 的机制研究.Published in:China Journal of Chinese Materia Medica, 2024, v. 49, n. 18, p. 4967, doi. 10.19540/j.cnki.cjcmm.20240531.401By:吴李征;陈晓鑫;孙博文;裴芳利;蓝丹彤;邝梓君;张诗媛;曾诚Publication type:Article
活血化瘀类口服中成药治疗子宫内膜异位症的 网状 Meta 分析.Published in:China Journal of Chinese Materia Medica, 2022, v. 47, n. 11, p. 3073, doi. 10.19540/j.cnki.cjcmm.20220224.501By:吴李征;柯妍;黄磊;林莉雯;黄英杰;裴芳利;曾诚Publication type:Article